Day: November 25, 2025

Not for distribution to U.S. news wire services or dissemination in the United States. LONDON, Ontario, Nov. 25, 2025 (GLOBE NEWSWIRE) — Abitibi Metals Corp. (CSE: AMQ) (OTCQB: AMQFF) (FSE: FW0) (“Abitibi” or the “Company”) has announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets, as sole bookrunner, and Haywood Securities, as co-lead, under which the underwriters (the “Underwriters”) have agreed to buy on bought deal basis 12,300,000 charity flow-through common shares (the “Charity Flow-Through Common Shares”), at a price of C$0.57 per Charity Flow-Through Common Share and 8,580,000 hard dollar common shares (the “Common Shares”), at a price of C$0.35 per Common Share, for total gross proceeds of approximately C$10 million (the “Offering”). The Company has...

The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift the clinical hold concerning the nebulizer device used in the Phase 2b trial An independent Data Monitoring Committee (DMC) completed a safety review following adverse events identified in the BX004 Phase 2b trial and recommended that the study continue with revised dosing Following the DMC review, the study protocol will be updated, and topline results are now expected in Q2 2026 NESS ZIONA, Israel, Nov. 25, 2025 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that the U.S. Food and Drug Administration (FDA) is continuing...

EMERYVILLE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge”, “the Company”), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will present at the Piper Sandler 37th Annual Healthcare Conference taking place in New York, NY on December 2-4, 2025. Kristen Fortney, PhD, CEO and co-founder, and Dov Goldstein, MD, CFO, are scheduled to participate in a fireside chat on Thursday, December 4 from 1:30 – 1:55 PM ET, and will participate in one-on-one meetings. To access the live webcast of the presentation, register here. Replays of the webcast will be available in the investor section of the Company’s website at https://ir.bioagelabs.com/,...

Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Nov. 25, 2025 (GLOBE NEWSWIRE) — South Pacific Metals Corp. (TSXV: SPMC) (FSE: 6J00) (“South Pacific Metals”, “SPMC” or the “Company”) is pleased to announce that it has entered into an agreement with a syndicate of agents led by BMO Capital Markets to market on a best-efforts basis by way of a private placement, up to C$8 million of units (the “Offering”) consisting of one common share and one-half of one common share purchase warrant (“Warrant”) of the Company (a “Unit”), at an indicative price of C$0.54 per Unit (the “Issue Price”). Each Warrant will entitle the holder to acquire one common share from the Company at a price of C$0.90 per share for a period of 24 months following the Closing Date (as defined below). The...

BEIJING, Nov. 25, 2025 (GLOBE NEWSWIRE) — Kaixin Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN) announced that it will effect a share consolidation of its ordinary shares, par value $0.045 each, at a ratio of 1-for-30, with a post-share consolidation par value $1.35 each, effective on December 1, 2025 (the “Share Consolidation”). The Company’s class A ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on December 1, 2025. Upon the market opening on December 1, 2025, the Company’s class A ordinary shares will continue to be traded on The Nasdaq Capital Market under the symbol “KXIN” with the new CUSIP number G5223X167. As a result of the Share Consolidation, every thirty (30) shares of the Company’s ordinary shares will be automatically consolidated into one (1) ordinary...

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of Anaptys, and/or other members of its executive leadership team, are scheduled to participate in multiple upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference, New York, NYFormat – Fireside chat and 1×1 investor meetings Date and Time – Tuesday, Dec. 2, 2025 at 1:30pm ETEvercore 8th Annual Healthcare Conference, Coral Gables, FLFormat – Fireside chat and 1×1 investor meetings Date and Time – Wednesday, Dec. 3, 2025 at 7:55am ETLive webcasts of the fireside chats will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events....

SUGAR LAND, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI) (“AOI”), a leading provider of advanced optical and HFC networking products that power the internet, today announced the Company will present via a fireside chat at the following investor conference: Event: Raymond James 2025 TMT & Consumer ConferenceDate: Tuesday, December 9th, 2025Presentation Time: 1:40 p.m. Eastern Time / 12:40 p.m. Central TimePresenter: Stefan Murry, Chief Financial Officer and Chief Strategy Officer A recording of the presentation will be available on the investor relations section of the company’s website at investors.ao-inc.com. About Applied Optoelectronics Applied Optoelectronics, Inc. (AOI) is a leading developer and manufacturer of advanced optical and HFC networking products that are the building...

DURHAM, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will present at the Piper Sandler Healthcare Conference on Wednesday, December 3, 2025, at 10:10 a.m. ET. A live webcast of the presentation, followed by a question-and-answer session will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event. About BioventusBioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments,...

WEST PALM BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — Onity Group Inc. (NYSE: ONIT) (“Onity” or the “Company”) today announced that Sean O’Neil, Executive Vice President and Chief Financial Officer with Onity Group, will present and host meetings with investors at the Bank of America Leveraged Finance Conference on December 2, 2025. Bank of America Leveraged Finance Conference Date: Tuesday, December 2, 2025Time: 3:30 p.m. to 4:00 p.m. Eastern Time This event will be webcast live through the link here. An investor presentation will be available on the Events & Presentation section of the Company’s shareholder relations page prior to the presentation. About Onity Group Onity Group Inc. (NYSE: ONIT) is a leading non-bank financial services company providing mortgage servicing and originations solutions through its primary...

HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ: GLDD), the largest provider of dredging services in the United States, announced today that the Company’s issuer credit rating has been upgraded to “B” from “B-” by S&P Global Ratings (“S&P”) with the outlook remaining stable. S&P based its ratings upgrade in part due to the Company’s improved revenues, earnings and expanding margins along with decreasing capital expenditures that will support healthy free cash flow generation over the next couple of years. The stable outlook reflects S&P’s expectation that Great Lakes will continue to grow revenue and expand margins through 2026 and their expectation that the Company will generate increasingly positive free cash flow as...